1Y Close · As of Aug 26, 2026
Yuhan operates in the Pharmaceuticals sector.
Legal name: YUHAN CORPORATION
In fiscal year 2025, Yuhan (000100) reported revenue of 2.19 trillion KRW, up 5.7% from 2.07 trillion KRW a year earlier.
Operating profit was 104.4 billion KRW and net income was 185.3 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 6.91 trillion KRW, with a P/B of 2.92.
These figures can be verified in the DART filing (receipt no. 20260312001236).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 2.2T | 104.4B | 185.3B |
| 2024 | 2.1T | 54.9B | 55.2B |
| 2023 | 1.9T | 56.8B | 134.0B |
Recent Filings
Serious Accident (Subsidiary Material Matters)
Fair Trade Compliance Status (Informational Disclosure)
Corporate Briefing (IR) (Informational Disclosure)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Treasury Stock: Treasury stock filings in the last 3 years: 1 cancellation(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-25 | Serious Accident (Subsidiary Material Matters) |
| 2026-08-24 | Fair Trade Compliance Status (Informational Disclosure) |
| 2026-08-18 | Corporate Briefing (IR) (Informational Disclosure) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-10 | Large Shareholding Report (Simplified) |